Benzinga's Top #PreMarket Losers

By: via Benzinga
Avalanche Biotechnologies Inc (NASDAQ: AAVL) shares declined 45.47 percent to $21.20 in pre-market trading following mixed AVA-101 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.